Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02670408 · ClinicalTrials.gov registry record
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
A clinical trial of Cardiac Transplant Disorder, sponsored by University of Alberta.
- Recruiting
- Registry status
- 900
- Enrollment target
- 13
- Study locations
NCT02670408: Recruiting study of Cardiac Transplant Disorder, sponsored by University of Alberta.
NCT02670408 is a study of Cardiac Transplant Disorder that is actively recruiting participants, run by University of Alberta. The registered enrollment target is 900 participants. The trial reports 13 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02670408, a study of Cardiac Transplant Disorder, is actively recruiting participants, sponsored by University of Alberta.
- RECRUITING
- Registry status
- 900 participants
- Enrollment target
- 13
- Study locations
Study Summary
Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.
Primary Outcome
Create a molecular classifier that predicts antibody mediated and T cell mediated rejection, based on the archetypal analysis.
Conditions Studied
Interventions
- PROCEDURE Endomyocardial biopsy
Study Locations (13)
Other
- Cardiac Transplantation Laboratory, The Victor Chang Cardiac Research Institute - Darlinghurst
- Department of Cardiac Surgery, Medical University of Vienna - Vienna
- Institute for Clinical and Experimental Medicine - IKEM - Prague
- Service de Néphrologie-Dialyse Adultes , Hôpital Necker-Enfants Malades - Paris
- Heart Failure and Heart Transplant Unit, University of Bologna - Bologna
- Advanced Heart Failure Transplant Unit - A Coruña
California
- UCLA Medical Centre - Los Angeles
- Cedars-Sinai Heart Institute - Los Angeles
Alberta
- Alberta Transplant Applied Genomics Center, University of Alberta - Edmonton
- Division of Cardiology, University of Alberta - Edmonton
Texas
- Annette C. and Harold C. Simmons Transplant Institute, BaylorScott&White Research Institute - Dallas
Utah
- Cardiovascular Medicine, University of Utah Health - Salt Lake City
Virginia
- Virginia Commonwealth University, Division of Cardiology - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2016-01 |
| Est. Completion | 2027-07 |
What NCT02670408 shows while recruiting
NCT02670408 is an observational study that tracks outcomes without assigning an intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Cardiac Transplant Disorder appearing as the primary indexed condition, and to 1 intervention - of which Endomyocardial biopsy is the first listed.
NCT02670408 lists 13 locations in 6 states (Other, California, Alberta).
Frequently Asked Questions
What is clinical trial NCT02670408 about?
NCT02670408 is a clinical study titled "Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation". Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.
What is the current status of trial NCT02670408?
This trial is currently recruiting. The enrollment target is 900 participants. The study started on 2016-01. Estimated completion is 2027-07.
What conditions does trial NCT02670408 study?
This clinical trial studies the following conditions: Cardiac Transplant Disorder.
What interventions are being tested in trial NCT02670408?
The interventions under investigation include: Endomyocardial biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02670408?
This trial is sponsored by University of Alberta, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02670408 being conducted?
This trial has 13 study locations across California, Texas, Utah, Virginia, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
- NCT03932786 · 900 participants
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia